Pregnancy-associated myocarditis is uncommon and remains poorly described. The spectrum of the disorder is wide, with the severe cases culminating in heart failure, cardiogenic shock and even maternal death. Diagnosis is typically made on imaging, serology and endocardiac biopsy findings with treatment being directed towards the underlying cause. We describe a case of likely peripartum myocarditis associated with severe early-onset pre-eclampsia.
MogosMFPianoMRMcFarlinBL, et al.
Heart failure in pregnant women: a concern across the pregnancy continuum. Circ Heart Fail2018;
11: e004005.
2.
StergiopoulosKLimaFVButlerJ.Heart failure in pregnancy: a problem hiding in plain sight. J Am Heart Assoc2019;
8: e012905.
3.
Hilfiker-KleinerDHaghikiaANonhoffJ, et al.
Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J2015;
36: 1090–1097.
4.
FerreiraVMSchulz-MengerJHolmvangG, et al.
Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol2018;
72: 3158–3176.
5.
KimRJFienoDSParrishTB, et al.
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation1999;
100: 1992–2002.
6.
CaforioALPankuweitSArbustiniE, et al.
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J2013;
34: 2636–2648. 48a–48d.
7.
CooperLTBaughmanKLFeldmanAM, et al.
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.J Am Coll Cardiol2007;
50: 1914–1931.
8.
SatohHSanoMSuwaK, et al.
Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis. World J Cardiol2014;
6: 585–601.
9.
MahrholdtHWagnerADeluigiCC, et al.
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation2006;
114: 1581–1590.
10.
ThomasGCohen AubartFChicheL, et al.
Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol2017;
44: 24–32.
11.
AringerMCostenbaderKDaikhD, et al.
2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis2019;
78: 1151–1159.
12.
PollackAKontorovichARFusterV, et al.
Viral myocarditis – diagnosis, treatment options, and current controversies. Nat Rev Cardiol2015;
12: 670–680.
MelvinKRRichardsonPJOlsenEG, et al.
Peripartum cardiomyopathy due to myocarditis. N Engl J Med1982;
307: 731–734.
15.
GłuszakMBorowieckaEBorowiecka-ElwertowskaA, et al.
Acute heart failure due to myocarditis in the first trimester of pregnancy. Ginekol Pol2013;
84: 476–479.
16.
van HaelstPLvan RossemMValentijnRM, et al.
Giant cell myocarditis: a fatal cause of dyspnea in pregnancy. Eur J Obstet Gynecol Reprod Biol2001;
100: 105–107.
17.
FabreASheppardMN.Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart2006;
92: 316–320.
18.
FarberPAGlasgowLA.Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. Am Heart J1970;
80: 96–102.
